Connect with us

Health

Jelly Roll’s wife says weight-loss drug sent her into ‘worst suicidal depression’

Published

on

Jelly Roll’s wife says weight-loss drug sent her into ‘worst suicidal depression’

NEWYou can now listen to Fox News articles!

This story discusses suicide. If you or someone you know is having thoughts of suicide, please contact the Suicide & Crisis Lifeline at 988 or 1-800-273-TALK (8255).

Bunnie XO, the wife of country singer Jelly Roll, is discussing how a weight-loss medication may have led to her experiencing a “dark” depression.

During an episode of her podcast “Dumb Blonde,” Bunnie, whose real name is Alyssa DeFord, revealed that she had been taking a new drug by Lilly called retatrutide (reta), which is currently in late-stage trials and not approved by the FDA.

WHAT ARE GLP-3S? MEET THE NEW GENERATION OF WEIGHT-LOSS DRUGS WITH THREE KEY INGREDIENTS

Advertisement

Bunnie, 45, confirmed that she received her dose from a “reputable wellness center” in Nashville, and felt sick within the first week. Within two weeks, she noticed she looked and felt slimmer. In the fourth week, she increased her dose by one unit, which is when she noticed the “mental numbness.”

“I literally got sent into the worst suicidal depression that I’ve had since 2020,” she said. “I’m talking like it scared me so bad. I didn’t think I was going to make it through the two weeks. Like I was praying to God.”

Bunnie XO, the wife of country singer Jelly Roll, is discussing how a weight-loss medication may have led to her experiencing a “dark” depression. (Christopher Polk/Penske Media via Getty Images)

The podcaster shared how she had “no emotion” and couldn’t listen to music that would typically “bring me joy.”

“You could see like my eyes were black,” she said. “I just drove in silence because I just couldn’t handle anything. It was either overstimulating or it was to the point where it just stole my joy. I had no joy, like nothing to live for. It was so dark.”

Advertisement

OBESITY EXPERT REVEALS THE BEST WAY TO DECIDE IF GLP-1S ARE RIGHT FOR YOU

After 20 days off the drug, Bunnie reported that her joy is “finally” returning, calling the experience a “battle.”

“My story is not what’s going to happen to you,” she shared with her listeners. “There’s so many people who are taking reta and love it and all that. But something happened with me.”

“My story is not what’s going to happen to you,” Bunnie XO shared with her listeners. “There’s so many people who are taking Reta and love it and all that. But something happened with me.” (Taylor Hill/WireImage)

Indiana-based drug-maker Lilly confirmed in a statement to Fox News Digital that retatrutide is an “investigational molecule that is legally available only to participants in Lilly’s clinical trials.”

Advertisement

“No one should consider taking anything claiming to be retatrutide outside of a Lilly-sponsored clinical trial,” the spokesperson wrote. “This was not a Lilly product, and the company continues to warn the public about the potential dangers of fake medicines.”

“This was not a Lilly product and the company continues to warn the public about the potential dangers of fake medicines.”

Fox News senior medical analyst Dr. Marc Siegel reacted in an interview with Fox News Digital, warning that retatrutide should not be taken while it has still not received FDA approval unless it is part of a clinical trial.

“This drug is new — known as a triple agonist (GLP-1, GIP and glucagon receptor agonist),” he said. “[It] has been linked potentially to depression and suicidal thoughts, as have the GLP-1 drugs, where some studies have shown increased psychiatric risks, so there is a potential link here.”

What is retatrutide?

The drug has received the nickname “GLP-3” because it targets the three hormones, which experts suggest could lead to more substantial weight loss.

Advertisement

Lilly announced results from its phase 3 trial TRIUMPH-4 in December, which tested retatrutide’s effect on weight loss and other health conditions.

“GLP-3s” are positioned to “approach bariatric surgery level outcomes,” although it doesn’t come without risks, one expert said. (iStock)

Participants with obesity and knee arthritis who took a 12-mg dose of retatrutide saw an average weight loss of 71.8 lbs (28.7%) at 68 weeks.

“We believe retatrutide could become an important option for patients with significant weight loss needs and certain complications, including knee osteoarthritis,” a Lilly spokesperson said in a statement to Fox News Digital.

Seven additional phase 3 trials for retatrutide are expected to wrap up in 2026. The drug could see FDA approval in 2027, according to GoodRx.

Advertisement

STUDY REVEALS HOW RAPIDLY WEIGHT COMES BACK AFTER QUITTING OBESITY MEDICATIONS

Despite limited data availability on the drug, the medication could also be applied to treat other conditions like type 2 diabetes, kidney disease, cardiovascular risk reduction and metabolic dysfunction, according to GoodRx and other experts.

Siegel confirmed that retatrutide’s side effects can be similar to other GLP-1s, including gastrointestinal symptoms and other rare reactions like pancreatitis, gallstones and heart arrhythmia.

Retatrutide could lead to more substantial weight loss for some patients, according to experts. (iStock)

Philip Rabito, M.D., a specialist in endocrinology, weight loss and wellness in New York City, shared in a previous interview with Fox News Digital that this new class of weight-loss drugs is positioned to “approach bariatric surgery level outcomes” — although it doesn’t come without risks.

Advertisement

“The novel glucagon‑agonist component introduces less‑understood long‑term safety considerations, so it is imperative that patients are followed closely by healthcare professionals experienced with this class of medicines, with cautious, stepwise use, despite the impressive efficacy,” he cautioned.

The mental health connection 

The potential link between mental health symptoms and weight-loss drugs is most likely due to the impact on the brain’s reward system, according to Siegel.

“Dopamine, serotonin and norepinephrine affect mood and appetite, reduce cravings and can have a positive effect on mood, but also can be negative,” he said. “Somewhat unpredictable.”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Dr. Peter Balazs, a hormone and weight-loss specialist in New York and New Jersey, noted that any presentation of significant depressive symptoms, particularly those including “psychotic features and suicidal ideation,” requires a full clinical evaluation.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“It is essential to understand the patient’s complete medical and psychiatric history, including other medical conditions, precise weight change dynamics, concomitant medications and psychosocial stressors,” he said. “Major depressive episodes are multifactorial — attributing them to a single agent without this context is premature.” 

Patients should be screened for mental health complications before taking weight-loss medication, experts suggest. (iStock)

Any individual experiencing these symptoms should “seek immediate professional help,” Balazs said.

“We are still learning about the psychiatric effects of these medications, even the ones that have already been approved,” he added.

Advertisement

CLICK HERE FOR MORE HEALTH STORIES

Bunnie’s age would typically place her in the perimenopausal stage, which can include “significant fluctuations” in reproductive hormones like estrogen, Balazs noted.

“Estrogen has well-documented neuroprotective and mood-stabilizing effects,” he said. “Its decline can render the brain more vulnerable to stress and dysregulation, potentially precipitating or exacerbating depressive episodes.”

Hormonal changes can impact mood when on a GLP-1 drug, according to experts. (iStock)

Obesity can also cause hormone shifts and inflammation that can interfere with normal brain function, sometimes affecting mood and emotional balance, the expert noted.

Advertisement

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Balazs stressed that experts should be “vigilant” in monitoring symptoms of people taking these medications. 

“Until a protocol is established, patients outside clinical trials should not inject these medications,” he cautioned. “Dose and dose-related responses can change the whole experience.”

Health

Measles outbreak poses risk of ‘irreversible’ brain damage, health officials warn

Published

on

Measles outbreak poses risk of ‘irreversible’ brain damage, health officials warn

NEWYou can now listen to Fox News articles!

South Carolina health officials are warning of “irreversible” neurological damage in children as measles-related hospitalizations climb in the state.

Of the 876 confirmed cases in the state’s upstate outbreak, at least 19 patients have been admitted with serious complications.

“Some of these complications include measles encephalitis, or inflammation of the brain, in children and pneumonia,” state epidemiologist Linda Bell said in a Feb. 4 briefing.

MEASLES EXPOSURE RISK IDENTIFIED AT MAJOR AIRPORT AND THEME PARK, HEALTH OFFICIALS WARN

Advertisement

Bell emphasized that the complication is particularly dangerous for young patients.

“Any time you have inflammation of the brain … there can be long-term consequences, things like developmental delays and impacts on the neurologic system that can be irreversible,” the expert warned.

Some of the more serious measles-related complications include measles encephalitis, or inflammation of the brain, in children, as well as pneumonia. (iStock)

While the state does not systematically track every medical complication, pneumonia is the leading cause of measles-related death among young children, affecting approximately one in every 20 infected minors, according to CDC data.

A total of 147 students are quarantined across 10 K-12 schools, Bell noted.

Advertisement

VACCINE DEBATE HEATS UP AS OFFICIALS WEIGH SPLITTING COMBINED MMR INTO SINGLE DOSES

The outbreak also poses a risk to expectant mothers. Because the MMR (measles, mumps and rubella) vaccine cannot be administered during pregnancy, several exposed women recently required emergency treatment with immune globulin to provide “passive immunity.”

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Bell noted that this is critical to “protect them against the high risk of complications during pregnancy and to protect their newborn babies.”

The measles virus is notoriously contagious, capable of lingering in the air for up to two hours after an infected person has left a room, experts say.

Advertisement

Pneumonia is the leading cause of death from measles in young children, affecting approximately one in every 20 infected minors. (iStock)

South Carolina saw a historic surge in vaccinations in January. In particular, Spartanburg County saw a 162% increase in MMR vaccinations compared to the previous year.

CLICK HERE FOR MORE HEALTH STORIES

“I’m hoping that what we can attribute [the vaccine surge] to is a wider recognition of the threat of this disease circulating in our communities and the desire for people to be protected against the complications,” Bell said in the briefing.

A new case in the Pee Dee region suggests the virus may be spreading beyond the initial upstate clusters through “unrecognized community transmission.” (Paul Bersebach/MediaNews Group/Orange County Register via Getty Images)

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Health officials continue to urge the public to seek vaccinations, especially as a new case in the Pee Dee region suggests the virus may be spreading beyond the initial upstate clusters through “unrecognized community transmission.”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

As far as the encephalitis and pneumonia fears, “these are complications we hope to prevent,” Bell added.

“Increasing vaccination coverage protects those who cannot be vaccinated, like young infants, pregnant women and those with weakened immune systems.”

Advertisement

Continue Reading

Health

Surgeons keep man alive without lungs, paving new path to transplant

Published

on

Surgeons keep man alive without lungs, paving new path to transplant

NEWYou can now listen to Fox News articles!

Surgeons at Northwestern Medicine in Chicago were able to keep a critically ill patient alive for 48 hours after removing both of his lungs, the hospital reported last week.

The patient, a 33-year-old Missouri resident whose name was not shared, was originally flown to Northwestern Memorial Hospital with lung failure linked to a flu infection in spring 2023.

When his condition escalated to severe pneumonia and sepsis, his heart stopped and the team performed CPR, according to a press release on the case.

GIRL WITH HEART FAILURE CALLS DAD WITH LIFE-CHANGING MESSAGE AFTER 200-DAY HOSPITAL STAY

Advertisement

“He had developed an infection of his lungs that just could not be treated with any antibiotics because it was resistant to everything,” said Ankit Bharat, M.D., chief of thoracic surgery and executive director of the Northwestern Medicine Canning Thoracic Institute. “That infection caused his lungs to liquify and then continued to progress to the rest of his body.”

The lungs needed to be removed to stop the spread of infection, but there was a dangerous risk of immediate heart failure.

“He had developed an infection of his lungs that just could not be treated with any antibiotics because it was resistant to everything,” said Ankit Bharat, M.D., chief of thoracic surgery and executive director of the Northwestern Medicine Canning Thoracic Institute (pictured). (Northwestern Medicine)

“The lungs act as a ‘shock absorber’ for the right side of the heart; when you remove them, the heart pumps against high resistance and can fail instantly,” Bharat told Fox News Digital. 

“Another critical danger is that without blood flowing from the lungs to the left heart, the left heart chambers can collapse or form deadly clots.”

Advertisement

MAN RECEIVES WORLD’S FIRST PIG LUNG TRANSPLANT IN GROUNDBREAKING MEDICAL PROCEDURE

While the man remained on life support, the medical team designed a “total artificial lung system” (TAL) that took over gas exchange (oxygenation and CO₂ removal) and maintained blood flow to the heart in hopes that it could keep the patient alive after both of his diseased lungs were removed.

“A key innovation here is that we maintained the heart’s natural physiology. By using a ‘flow-adaptive’ design, we allowed the patient’s own heart to regulate blood flow, rather than forcing it with a machine,” Bharat said.

“Just one day after we took out the lungs, his body started to get better because the infection was gone.”

“Just one day after we took out the lungs, his body started to get better because the infection was gone.”

Advertisement

After 48 hours, the patient was stable enough to proceed with a double-lung transplant. Two years later, he is back to his regular routine.

CLICK HERE FOR MORE HEALTH STORIES

“The patient is doing remarkably well,” Dr. Bharat said. “He has excellent lung function, his heart function is preserved and he is completely functionally independent.”

This was the first successful application of this specific type of system, according to the medical team.

The medical team designed a “total artificial lung system” that maintained blood flow to the heart until the transplant could be placed. (Northwestern Medicine)

Advertisement

“While the concept of removing lungs and bridging to transplant has been attempted in rare cases historically, those prior attempts faced significant limitations regarding blood flow management and the risk of clots,” Bharat told Fox News Digital. 

“Our system is novel because it includes a self-regulating ‘shunt’ that mimics the natural physics of the lung to protect the heart, and it uses dual return tubes to maintain normal blood flow through the left heart chambers.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

In a case study, which was published last week in the Cell Press journal Med, experts revealed a “molecular analysis” of the removed lungs, showing extensive scarring and damage. This supports the idea that in some severe cases of acute respiratory distress syndrome, transplantation may be the only viable option.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Advertisement

Researchers hope that the TAL system could eventually be a viable strategy for patients who are waiting for donor lungs — specifically, those with severe acute respiratory distress syndrome (ARDS) along with necrotizing pneumonia or septic shock.

The patient’s new transplant is shown at left, and his old lungs are shown at right. “This technology allows us to ‘clean the slate’ by removing the infection, stabilizing the patient and bridging them to a successful transplant,” the lead surgeon said. (Northwestern Medicine)

“These patients have a mortality rate exceeding 80% and are often turned down for transplant because they are too infected,” Dr. Bharat said. “This technology allows us to ‘clean the slate’ by removing the infection, stabilizing the patient and bridging them to a successful transplant.”

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

In the future, he added, they hope to develop durable, implantable artificial lungs that patients can live with long-term, not just as a bridge to transplant.

Advertisement

Continue Reading

Health

Can Arnold Schwarzenegger’s New Supplement Stack Help Women 50+ Lose Weight?

Published

on

Can Arnold Schwarzenegger’s New Supplement Stack Help Women 50+ Lose Weight?


Advertisement



Arnold Schwarzenegger Swears by These Supplements for 50+ Weight Loss | Woman’s World




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Trending